Subject of file

Mundipharma Pharmaceuticals Ltd.

file no.3102 active2019-03-31 – 2019-11-06 authorities3 spend areas1

Lane I

Solo awards

€112k

awarded across 3 sole-awardee contracts

The only credibly per-supplier-attributable money in this dossier — eTenders names a single awardee.

Lane II

Framework participations

multi-supplier frameworks · ceiling exposure €0

Per-supplier earnings cannot be derived — call-off splits between co-suppliers aren't in the source data. Read the count, not the money.

Lobbying register

11 matches

1 May, 2020 to 31 Aug, 2020 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Outline the potential value from increased adoption of biosimilar medicines

1 Jan, 2020 to 30 Apr, 2020 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Submission on potential value from increased adoption of biosimilar medicines

1 Sep, 2019 to 31 Dec, 2019 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Budget Submission regarding the value presented by greater biosimilar adoption

1 May, 2019 to 31 Aug, 2019 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Meeting requested to discuss the present biosimilars landscape

1 Jan, 2019 to 30 Apr, 2019 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Meeting to discuss the present biosimilars landscape

1 Sep, 2018 to 31 Dec, 2018 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Meeting to discuss the present biosimilars landscape

1 May, 2018 to 31 Aug, 2018 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Biosimilars landscape

1 Jan, 2018 to 30 Apr, 2018 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Limited Ireland|Arkle Rd, Sandyford Industrial Estate, Sandyford, Dublin

Meeting requested to discuss the present biosimilars landscape

1 May, 2017 to 31 Aug, 2017 · Lobbyist: Hume Brophy · Client: Mundipharma Pharmaceuticals Ltd|Millbank House, Arkle Rd, Sandyford, Dublin 18|[email protected]|0

Meeting requested to discuss the present biosimilars landscape

1 Sep, 2016 to 31 Dec, 2016 · Lobbyist: Hume Brophy · Client: MUNDIPHARMA PHARMACEUTICALS LIMITED|MILLBANK HOUSE ARKLE ROAD SANDYFORD DUBLIN 18|[email protected]

Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2016

1 May, 2016 to 31 Aug, 2016 · Lobbyist: Hume Brophy · Client: MUNDIPHARMA PHARMACEUTICALS LIMITED|MILLBANK HOUSE ARKLE ROAD SANDYFORD DUBLIN 18|[email protected]

Drugs Policy

Top authorities

01 Beaumont Hospital 1
02 St James's Hospital 1
03 St. Vincent's University Hospital 1

Spend areas

01 Pharmaceutical products. 2

Solo awards

3 records

Sole-awardee contracts. Awarded values reflect actual money paid to this supplier.

Date	Authority	Contract	Procedure	Estimated	Awarded
2019-11-06	Beaumont Hospital	SINGLE-PARTY FRAMEWORK AGREEMENT FOR THE SUPPLY OF INTRAEVNOUS TRASTUZUMAB PHARMACEUTICAL PRODUCTS TED CAN	Open Procedure	€800k	€112k
2019-05-31	St James's Hospital	IV Trastuzumab / Biosimilar TED CAN	Open Procedure	€750k	€1
2019-03-31	St. Vincent's University Hospital	THE SUPPLY OF RITUXIMAB FOR INFUSION TED CAN	Open Procedure	—	—

Framework participations

0 records

No multi-supplier framework participations on record.